financetom
Business
financetom
/
Business
/
Alexander Hamilton's bank is getting a new name: BNY
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alexander Hamilton's bank is getting a new name: BNY
Jun 11, 2024 5:12 AM

NEW YORK (Reuters) - The oldest U.S. bank is getting a new name.

Bank of New York Mellon ( BK ) is embracing BNY as its new moniker, CEO Robin Vince wrote in a memo to employees on Tuesday. The company also unveiled block-lettered signs with the three-letter name across its major offices.

Since it was founded 240 years ago by Alexander Hamilton, BNY has grown to oversee $48.8 trillion in assets, and serves as a bank for other financial institutions, known as a custodian.

It is the longest continuously operating company in New York City and the company's founding even predates the signing of the U.S. constitution.

"Though we have long been known as both trusted and resilient, to exist and thrive for more than two centuries has also required a continuous focus on innovation," Vince wrote.

Since taking the helm in March 2022, Vince has brought in new leadership and focused on growth in areas like real-time payments and artificial intelligence, while boosting efficiency. The executive spent 26 years at Goldman Sachs, where he rose to become its chief risk officer.

BNY's stock has risen almost 17% in 2024, compared with 13% for a broader S&P 500 index of bank shares. Its earnings per share and revenue climbed last year.

The bank's rebrand was its first since it slimmed down to BNY Mellon 17 years ago. It follows a trend toward brevity on Wall Street after decades of mergers and acquisitions led to ever-lengthier names.

BNY also introduced a new teal arrow logo to precede its all-capitals name, which is already a widely used shorthand in financial circles. Some of its divisions will also be renamed: BNY Investments, BNY Wealth and BNY Pershing.

The bank is rolling out new branded merchandise like sweatshirts to coincide with the launch.

Still, its legal name will remain The Bank of New York Mellon Corporation ( BK ).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Medical aesthetic device maker Venus Concept's Q3 revenue misses
Medical aesthetic device maker Venus Concept's Q3 revenue misses
Nov 13, 2025
Overview * Venus Concept Q3 2025 revenue down 8% yr/yr, missing analyst expectations * Net loss widened to $22.5 mln in Q3, compared to $9.3 mln last year * Company completed debt-to-equity exchange, reducing debt by 24% Outlook * Company is not providing financial guidance for fiscal year 2025 * Company targets sequential growth in Q4 with Venus NOVA launch...
GoHealth Q3 revenue misses estimates on reduced Medicare Advantage volume
GoHealth Q3 revenue misses estimates on reduced Medicare Advantage volume
Nov 13, 2025
Overview * GoHealth Q3 2025 revenue declines 71% yr/yr, missing analyst expectations * Adjusted EBITDA for Q3 misses estimates, reflecting strategic pullback in Medicare Advantage * Company focuses on retention and quality amid changing Medicare market dynamics Outlook * Company secured superpriority term loan facility to enable strategic flexibility Result Drivers * MEDICARE ADVANTAGE PULLBACK - Co reduced Medicare Advantage...
Alliance Laundry Q3 Adjusted Earnings, Revenue Rise
Alliance Laundry Q3 Adjusted Earnings, Revenue Rise
Nov 13, 2025
07:11 AM EST, 11/13/2025 (MT Newswires) -- Alliance Laundry ( ALH ) reported Q3 adjusted earnings Thursday of $0.28 per share, up from $0.19 a year earlier. An analyst surveyed by FactSet expected $0.22. Net revenue for the quarter ended Sept. 30 was $437.6 million, up from $384.3 million. Analysts polled by FactSet expected $423.5 million. ...
Aura Biosciences Q3 net loss widens as R&D costs rise
Aura Biosciences Q3 net loss widens as R&D costs rise
Nov 13, 2025
Overview * Aura Biosciences ( AURA ) reports Q3 net loss of $26.1 mln, up from $21.0 mln last year * R&D expenses rise to $22.2 mln due to ongoing clinical trials Outlook * Aura expects Phase 3 CoMpass trial enrollment completion in 2026 * Topline data for CoMpass trial expected in Q4 2027 * Phase 1b/2 trial data for...
Copyright 2023-2025 - www.financetom.com All Rights Reserved